{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:09Z","timestamp":1792022829006,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.02.014","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T11:57:19Z","timestamp":1455451039000},"page":"1515-1523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Global epidemiology of capsular group W meningococcal disease (1970\u20132015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex"],"prefix":"10.1016","volume":"34","author":[{"given":"Mustapha M.","family":"Mustapha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane W.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.02.014_bib0735","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0740","first-page":"709","article-title":"Comparative epidemiologic study of meningococcic cerebrospinal meningitis in temperate regions and in the meningitis belt in Africa. Attempt at synthesis","volume":"28","author":"Lapeyssonnie","year":"1968","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0745","first-page":"123","article-title":"Meningococcal disease control in countries of the African meningitis belt, 2014","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0750","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.02.014_bib0755","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1016\/j.vaccine.2009.04.070","article-title":"Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis","volume":"27","author":"Stephens","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0760","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mib.2014.11.006","article-title":"Neisseria meningitidis: pathogenesis and immunity","volume":"23","author":"Pizza","year":"2015","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0765","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/gbe\/evr119","article-title":"Extensive genomic variation within clonal complexes of Neisseria meningitidis","volume":"3","author":"Hao","year":"2011","journal-title":"Genome Biol Evol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0770","doi-asserted-by":"crossref","first-page":"15082","DOI":"10.1073\/pnas.0712019105","article-title":"Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis","volume":"105","author":"Buckee","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0775","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/gbe\/evt116","article-title":"Homologous recombination drives both sequence diversity and gene content variation in Neisseria meningitidis","volume":"5","author":"Kong","year":"2013","journal-title":"Genome Biol Evol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0780","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.aje.a120854","article-title":"Prevalence of meningococcal serogroups and description of three new groups","volume":"87","author":"Evans","year":"1968","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0785","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/344273","article-title":"Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964\u20131998","volume":"35","author":"Brundage","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0790","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1542\/peds.64.2.218","article-title":"Disease due to serogroup W135 Neisseria meningitidis","volume":"64","author":"Griffiss","year":"1979","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0795","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/jcm.8.5.621-622.1978","article-title":"Meningitis caused by Neisseria meningitidis serogroup 135","volume":"8","author":"Kleiman","year":"1978","journal-title":"J Clin microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0800","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","article-title":"Serogroup W135 meningococcal disease in Hajj pilgrims","volume":"356","author":"Taha","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0805","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/340414","article-title":"Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex","volume":"185","author":"Mayer","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0810","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3201\/eid1601.091026","article-title":"Cluster of serogroup W135 meningococci, southeastern Florida, 2008\u20132009","volume":"16","author":"Doyle","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0815","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3201\/eid2003.131407","article-title":"Neisseria meningitidis serogroup W, Burkina Faso, 2012","volume":"20","author":"MacNeil","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0820","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3201\/eid2102.140746","article-title":"Neisseria meningitidis ST-11 clonal complex, Chile 2012","volume":"21","author":"Araya","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0825","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3201\/eid1909.130160","article-title":"Spread of Neisseria meningitidis serogroup W clone, China","volume":"19","author":"Zhou","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0830","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0835","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/525260","article-title":"Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa","volume":"46","author":"von Gottberg","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0840","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/INF.0b013e31828e9e91","article-title":"Invasive serogroup w meningococcal disease in children: a national survey from 2001 to 2008 in France","volume":"32","author":"Gaschignard","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0845","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(02)07716-4","article-title":"W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001","volume":"359","author":"Hahne","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0850","first-page":"20","article-title":"Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015","author":"Campbell","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0855","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3201\/eid1609.100510","article-title":"Increase in Neisseria meningitidis serogroup W135, Niger, 2010","volume":"16","author":"Collard","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0860","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/1471-2334-13-576","article-title":"Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination","volume":"13","author":"Collard","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0865","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/507339","article-title":"The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002\u20132005","volume":"43","author":"Traore","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0870","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3201\/eid1407.070938","article-title":"A prospective study of etiology of childhood acute bacterial meningitis, Turkey","volume":"14","author":"Ceyhan","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0875","doi-asserted-by":"crossref","first-page":"e66006","DOI":"10.1371\/journal.pone.0066006","article-title":"Molecular Characterization of Invasive Neisseria meningitidis Strains Isolated in Chile during 2010\u20132011","volume":"8","author":"Barra","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0880","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JCM.02390-08","article-title":"W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina","volume":"47","author":"Efron","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0885","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(87)90115-X","article-title":"Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135","volume":"82","author":"Brasier","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0890","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF01962346","article-title":"Myopericarditis with cardiac tamponade caused by Neisseria meningitidis serogroup W135","volume":"7","author":"Ejlertsen","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0895","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s100960000289","article-title":"Neisseria meningitidis serogroup W-135 primary monarthritis of the hip in an immunocompetent child","volume":"19","author":"Apfalter","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0900","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/421022","article-title":"Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases","volume":"38","author":"Faye","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0905","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1119-3077.146977","article-title":"Outbreak of serotype W135 Neisseria meningitidis in central river region of the Gambia between February and June 2012: a hospital-based review of paediatric cases","volume":"18","author":"Osuorah","year":"2015","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0910","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/426436","article-title":"Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing","volume":"40","author":"Parent du Chatelet","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0915","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jinf.2009.11.014","article-title":"Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil","volume":"60","author":"Lemos","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0920","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.42.9.4158-4163.2004","article-title":"Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000","volume":"42","author":"Taha","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0925","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ebiom.2015.09.007","article-title":"Genomic epidemiology of hypervirulent serogroup W, ST-11 Neisseria meningitidis","volume":"2","author":"Mustapha","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0935","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0940","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1699-0463.1998.tb01379.x","article-title":"Population genetics and molecular epidemiology of Neisseria meningitidis","volume":"106","author":"Caugant","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0945","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/167.6.1320","article-title":"Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis","volume":"167","author":"Wang","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0950","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(86)90123-6","article-title":"Meningococcal serotypes and serogroup B disease in north-west Europe","volume":"2","author":"Poolman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0955","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/infdis\/162.4.867","article-title":"Clones of serogroup B Neisseria meningitidis causing systemic disease in the Netherlands, 1958\u20131986","volume":"162","author":"Caugant","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0960","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1995.03520290042027","article-title":"The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis","volume":"273","author":"Whalen","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0965","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/infdis\/164.2.368","article-title":"Meningococcal disease in the United States--1986, Meningococcal Disease Study Group","volume":"164","author":"Pinner","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0970","doi-asserted-by":"crossref","first-page":"e46019","DOI":"10.1371\/journal.pone.0046019","article-title":"Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine","volume":"7","author":"Caugant","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0975","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JCM.39.7.2695-2699.2001","article-title":"Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent Hajj pilgrimage","volume":"39","author":"Molling","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0980","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiu842","article-title":"Changes in the population structure of invasive Neisseria meningitidis in the United States after quadrivalent meningococcal conjugate vaccine licensure","author":"Wang","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0985","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12866-015-0469-6","article-title":"Characterization of invasive Neisseria meningitidis strains from Quebec, Canada, during a period of increased serogroup B disease, 2009\u20132013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets","volume":"15","author":"Law","year":"2015","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0990","first-page":"109","article-title":"Diversity of Neisseria meningitidis invasive isolates in Italy in the period 2008\u20132010","volume":"53","author":"Neri","year":"2012","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.014_bib0995","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3201\/eid1502.080988","article-title":"Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007\u20132008","volume":"15","author":"Massenet","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1000","doi-asserted-by":"crossref","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","article-title":"Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso","volume":"6","author":"Delrieu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1005","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/JCM.43.3.1437-1438.2005","article-title":"Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains","volume":"43","author":"Nicolas","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-6976.2006.00057.x","article-title":"Molecular typing of meningococci: recommendations for target choice and nomenclature","volume":"31","author":"Jolley","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1015","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/IAI.63.4.1484-1490.1995","article-title":"Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques","volume":"63","author":"Bash","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1020","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/mic.0.26131-0","article-title":"Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component","volume":"149","author":"Thompson","year":"2003","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1099\/jmm.0.46451-0","article-title":"Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001","volume":"55","author":"Lemos","year":"2006","journal-title":"J Med Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.02.014_bib1030","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1016\/j.vaccine.2007.04.038","article-title":"The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002","volume":"25","author":"Koumare","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/651505","article-title":"Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000\u20132005","volume":"201","author":"Harrison","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1040","first-page":"33","article-title":"Pulsed-field gel electrophoresis","volume":"15","author":"Kaufmann","year":"1998","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/2047773212Y.0000000070","article-title":"Epidemiologic pattern of meningococcal meningitis in northern Cameroon in 2007\u20132010: contribution of PCR-enhanced surveillance","volume":"107","author":"Massenet","year":"2013","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3201\/eid0803.010308","article-title":"Recent increase in meningitis caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon","volume":"8","author":"Fonkoua","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.micinf.2005.01.003","article-title":"The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37\/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso","volume":"7","author":"Njanpop-Lafourcade","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ebiom.2015.01.004","article-title":"Genomic analysis of the evolution and global spread of hyper-invasive meningococcal lineage 5","volume":"2","author":"Harrison","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1065","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/JCM.03524-14","article-title":"Genome-based characterization of emergent invasive Neisseria meningitidis serogroup Y isolates in Sweden from 1995 to 2012","volume":"53","author":"Toros","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"Scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1075","unstructured":"Mustapha MM MJ, Fernandez JO, de Lemos APS, Wang X, Mayer LW, Harrison LH. Capsular Switching and Global Spread of Neisseria Meningitidis Serogroup W, ST-11. International Pathogenic Neisseria Conferences, IPNC. Asheville, North Carolina, USA: IPNC; 2014."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1080","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/IAI.73.6.3322-3329.2005","article-title":"Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa","volume":"73","author":"Stevanin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1090","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/IAI.00181-09","article-title":"Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains","volume":"77","author":"Beddek","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1477-8939(03)00019-X","article-title":"W135 in Africa: origins, problems and perspectives","volume":"1","author":"Kelly","year":"2003","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1100","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"5","author":"Pajon","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.12688\/f1000research.3881.1","article-title":"Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009","volume":"3","author":"Ispasanie","year":"2014","journal-title":"F1000Res"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1099\/jmm.0.000006","article-title":"Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009\u20132013","volume":"64","author":"Tsang","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1115","first-page":"21","article-title":"Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989\u20131991","volume":"42","author":"Jackson","year":"1993","journal-title":"MMWR CDC Surveill Summ"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1120","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1125","first-page":"17","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada: 1 January 1999, through 31 December, 2001","volume":"30","author":"Squires","year":"2004","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S0022172400063828","article-title":"Meningococcal disease in South Australia: incidence and serogroup distribution 1971\u20131980","volume":"90","author":"Hansman","year":"1983","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-4453(86)93583-8","article-title":"Meningococcal disease in The Netherlands, 1959\u20131981: the occurrence of serogroups and serotypes 2a and 2b of Neisseria meningitidis","volume":"12","author":"de Marie","year":"1986","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1140","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(82)91533-1","article-title":"Emergence of meningococcal meningitis caused by W 135 subgroup in Africa","volume":"2","author":"Denis","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1365-3156.1998.00300.x","article-title":"Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa","volume":"3","author":"Kwara","year":"1998","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1150","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit","volume":"55","author":"Meningococcal Reference","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2334-6-25","article-title":"Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan","volume":"6","author":"Chiou","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1160","first-page":"177","article-title":"Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998","volume":"26","author":"Squires","year":"2000","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/JCM.33.1.53-57.1995","article-title":"Meningococcal infections in the Province of Quebec, Canada, during the period 1991 to 1992","volume":"33","author":"Ringuette","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5694\/j.1326-5377.1988.tb120668.x","article-title":"Meningococcal serogroups in New South Wales, 1977\u20131987","volume":"149","author":"Munro","year":"1988","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1175","first-page":"861","article-title":"Association of meningococcal serogroups with the course of disease in the Netherlands, 1959\u201383","volume":"65","author":"Spanjaard","year":"1987","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/clind\/16.2.237","article-title":"Meningococcal disease in the Netherlands, 1958\u20131990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis","volume":"16","author":"Scholten","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1185","first-page":"219","article-title":"Active surveillance of meningococcal meningitis in Poland","volume":"6","author":"Tyski","year":"1998","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1007303502274","article-title":"Pattern of bacterial meningitis in Italy, 1994","volume":"13","author":"Salmaso","year":"1997","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1086\/346154","article-title":"Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy","volume":"36","author":"Mastrantonio","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1200","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1136\/bmj.284.6329.1618","article-title":"Meningococcal disease in Scandinavia","volume":"284","author":"Peltola","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1574-695X.1999.tb01716.x","article-title":"Recent emergence of serogroup C meningococcal disease in Greece","volume":"23","author":"Kremastinou","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF01643964","article-title":"Meningococcal infections in the German Democratic Republic 1971\u20131984","volume":"14","author":"Grahlow","year":"1986","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0022172400064688","article-title":"Meningococcal infections in Scotland 1972\u201382","volume":"93","author":"Fallon","year":"1984","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1220","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0035-9203(86)90303-2","article-title":"The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa","volume":"80","author":"Greenwood","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1225","first-page":"23","article-title":"Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia","volume":"52","author":"Raja","year":"2006","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1230","first-page":"708","article-title":"Epidemiology of invasive meningococcal disease in 13 government hospitals in Thailand, 1994\u20131999","volume":"31","author":"Pancharoen","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1235","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0950268800004805","article-title":"Determinants of case fatality rates of meningococcal disease during outbreaks in Makkah, Saudi Arabia, 1987\u201397","volume":"125","author":"El Bushra","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1240","first-page":"184","article-title":"Meningococcal infection among pilgrims visiting Madinah Al-Munawarah despite prior A-C vaccination","volume":"50","author":"Yousuf","year":"2000","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1245","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3201\/eid0906.020565","article-title":"Serogroup W-135 meningococcal disease during the Hajj, 2000","volume":"9","author":"Lingappa","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1250","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trstmh.2012.01.010","article-title":"Characterization of Neisseria meningitidis isolates from Egypt using multilocus sequence typing","volume":"106","author":"Klena","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1255","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/169.4.912","article-title":"Epidemiology of pediatric meningitis caused by Haemophilus influenzae type b. Streptococcus pneumoniae, and Neisseria meningitidis in Israel: a 3-year nationwide prospective study. Israeli Pediatric Bacteremia and Meningitis Group","volume":"169","author":"Dagan","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jiph.2015.01.009","article-title":"Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987\u20132013","volume":"8","author":"Husain","year":"2015","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1265","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1270","unstructured":"Meningococcal disease, serogroup W 135. Wkly Epidemiol Rec. 2000;75:173\u201380."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tmaid.2011.01.004","article-title":"Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States","volume":"9","author":"Memish","year":"2011","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1280","doi-asserted-by":"crossref","unstructured":"Meningococcal disease, serogroup W135 (update). Wkly Epidemiol Rec. 2001;76:213\u20134.","DOI":"10.1016\/S0140-6736(00)05293-4"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1285","doi-asserted-by":"crossref","unstructured":"Meningococcal disease, serogroup W135. Wkly Epidemiol Rec. 2001;76:141\u20132.","DOI":"10.1016\/S0140-6736(00)05293-4"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1290","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.4161\/hv.29678","article-title":"Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005\u20132012 in Turkey. A multicenter prospective surveillance study","volume":"10","author":"Ceyhan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1295","unstructured":"Weekly feedback bulletin on cerebrospinal meningitis. Meningitis Weekly Bulletin. http:\/\/www.who.int\/csr\/disease\/meningococcal\/epidemiological\/en\/index.html: World Health Organization; 2002\u20132015."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1300","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JCM.40.3.1083-1084.2002","article-title":"Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger","volume":"40","author":"Taha","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1305","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(02)00455-3","article-title":"Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso","volume":"2","author":"Decosas","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1310","unstructured":"Meningitis in Chad, Niger and Nigeria: 2009 epidemic season. Wkly Epidemiol Rec. 2010;85:47\u201363."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1315","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2334-13-363","article-title":"Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine","volume":"13","author":"Kristiansen","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1320","doi-asserted-by":"crossref","first-page":"e68401","DOI":"10.1371\/journal.pone.0068401","article-title":"Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin","volume":"8","author":"Njanpop-Lafourcade","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1325","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","author":"Kristiansen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3201\/eid2101.140256","article-title":"Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013","volume":"21","author":"Gamougam","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1335","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3201\/eid1302.051553","article-title":"Meningococcal disease in South Africa, 1999\u20132002","volume":"13","author":"Coulson","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1340","doi-asserted-by":"crossref","first-page":"e19717","DOI":"10.1371\/journal.pone.0019717","article-title":"Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients \u2264\u00a015 years in Manhica, rural Mozambique","volume":"6","author":"Ibarz-Pavon","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1345","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1017\/S0950268814001149","article-title":"Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America","volume":"142","author":"Abad","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1350","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2008.07.014","article-title":"High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil","volume":"57","author":"Weidlich","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1355","doi-asserted-by":"crossref","first-page":"e58065","DOI":"10.1371\/journal.pone.0058065","article-title":"Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010","volume":"8","author":"Sorhouet-Pereira","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1360","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2015.10.055","article-title":"The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations","volume":"33","author":"Safadi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1365","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1086\/377739","article-title":"Neisseria meningitidis strains isolated from invasive infections in France (1999\u20132002): phenotypes and antibiotic susceptibility patterns","volume":"37","author":"Antignac","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1370","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3201\/eid1906.120515","article-title":"Travel-related Neisseria meningitidis serogroup W135 infection, France","volume":"19","author":"Taha","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1375","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/j.vaccine.2012.03.011","article-title":"Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines","volume":"30","author":"Ladhani","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1380","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1385","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1469-0691.2006.01451.x","article-title":"Neisseria meningitidis W-135 in the Basque Country, northern Spain","volume":"12","author":"Vicente","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1390","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1016\/j.vaccine.2015.06.032","article-title":"Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006\u20132014","volume":"33","author":"Stefanelli","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1395","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1016\/j.vaccine.2012.08.019","article-title":"Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy","volume":"30","author":"Bechini","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1400","first-page":"40","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada, 2006\u20132011","author":"Li","year":"2014","journal-title":"CCDR"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1405","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1017\/S095026880999104X","article-title":"Emergence and disappearance of W135 meningococcal disease","volume":"138","author":"Wilder-Smith","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijid.2014.08.022","article-title":"CC4821 serogroup W meningococcal disease in China","volume":"29","author":"He","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4172\/2332-0877.1000165","article-title":"Neiserria meningitis due to W135 strain from South India","volume":"2","author":"Devasena","year":"2014","journal-title":"J Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1420","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3201\/eid2009.140349","article-title":"Urethritis caused by novel Neisseria meningitidis serogroup W in man who has sex with men, Japan","volume":"20","author":"Hayakawa","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1425","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3346\/jkms.2015.30.5.662","article-title":"Cluster of serogroup W-135 meningococcal disease in 3 military recruits","volume":"30","author":"Jo","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1430","unstructured":"Health AGDo. Australian Meningococcal Surveillance Programme annual reports. 2014."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1435","unstructured":"Team HI. The epidemiology of meningococcal disease in New Zealand 2008\u20132013. Meningococcal Disease Reports: Institute of Environmental Science and Research Limited; 2014."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1440","unstructured":"Mustapha MM, Marsh JW, Fernandez JO, Lemos APS, Wang X, Mayer LW, et al. Capsular switching and global spread of Neisseria meningitidis serogroup W, ST-11. International Pathogenic Neisseria Conferences, IPNC. Asheville, North Carolina, USA: IPNC; 2014."},{"key":"10.1016\/j.vaccine.2016.02.014_bib1445","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(89)90439-X","article-title":"Intercontinental spread of an epidemic group A Neisseria meningitidis strain","volume":"2","author":"Moore","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1450","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14760584.5.3.319","article-title":"Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines","volume":"5","author":"Mueller","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1455","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.014_bib1460","first-page":"6","article-title":"Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013\u201314","author":"Funk","year":"2014","journal-title":"PLoS currents"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:32:07Z","timestamp":1718361127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":146,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001560"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global epidemiology of capsular group W meningococcal disease (1970\u20132015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}